Bio-Path raises additional $1.1M ATM capacity after completing initial $2M sale

BIO-PATH HOLDINGS, INC.

Sold 436,511 shares for ~$2.0M gross proceeds under prior ATM; offering terminated April 19, 2024.
New ATM prospectus supplement filed to sell up to additional $1,107,871 of common stock.
Proceeds from the expanded ATM will be used for working capital and general corporate purposes.
H.C. Wainwright & Co. acts as sales agent; no minimum offering and no obligation to sell.
Shares offered under existing shelf registration statement (333-265282) declared effective June 14, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.